To evaluate the effect of Dharneeya Vegas(suppressible urges like krodha ,irshya lobha e.t.c.) and Adharneeya Vegas(Non suppressible urges like mutra,mala,vomiting e.t.c.) in Psoriasis.
Not Applicable
- Conditions
- Health Condition 1: null- EK KUSHTHA
- Registration Number
- CTRI/2018/01/011124
- Lead Sponsor
- IPGT RA GAU Jamnagar Gujarat India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients having signs and symptoms of Ek
Kushtha(Psoriasis).
2.Age: 20 to 60 years
3.Gender: Both Males and females.
Exclusion Criteria
1.Age: <20 yrs & >60yrs.
2.Patients having other diseases like HTN,
Diabetes and other complications
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method finding out the role of Dharneeya and Adharneeya Vega in the manifestation of Ek Kustha(Psoriasis).Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method Improvement of health and quality of life of the patientsTimepoint: 1.5 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link Dharneeya/Adharneeya Vegas to Th17-mediated inflammation in psoriasis?
How does behavioral management of Dharneeya Vegas compare to TNF inhibitors in psoriasis treatment efficacy?
Are there specific biomarkers in psoriasis patients that correlate with response to Adharneeya Vegas modulation?
What adverse events are associated with Ayurvedic interventions targeting Dharneeya Vegas in CTRI/2018/01/011124?
How do Dharneeya Vegas management strategies integrate with current biologic therapies for psoriasis?